Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Sidney Hillman Health Center of Rochester et al v. Abbott Laboratories et al
Case Number:
1:13-cv-05865
Court:
Nature of Suit:
470(Racketeer/Corrupt Organization)
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
June 30, 2016
RICO Claims Don't Hold Up In Abbott Off-Label Use Suit
An Illinois federal judge held Wednesday that Racketeer Influenced and Corrupt Organizations Act claims over Abbott Laboratories' alleged off-label promotion of seizure drug Depakote fail because two health benefit plans didn't show a sufficiently direct link between the company's misrepresentations and their injuries.
-
August 16, 2013
Health Plans Sue Abbott Over Depakote Off-Label Scheme
Abbott Laboratories Inc. was hit with a proposed class action in Illinois federal court Friday by three health benefit plans alleging it unfairly reaped hundreds of millions of dollars from third-party payors through off-label marketing and kickbacks for prescriptions of anti-seizure medication Depakote.